Search Results 101-110 of 28152 for B cell lymphomas

  1. Lymphoma - Doctors and departments - Mayo Clinic

    Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...

  2. LymphoStats - Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    These models and tools have been developed by the lab or in collaboration with lab members. Prognostic models. Diffuse large B-cell lymphoma. Newly diagnosed.

  3. Non-Hodgkin lymphoma - Care at Mayo Clinic

    Mayo Clinic offers chimeric antigen receptor (CAR)-T cell therapy for people with certain types of B-cell non-Hodgkin lymphoma. This treatment, offered through ...

  4. Burkitt lymphoma - Diagnosis and treatment - Mayo Clinic

    Burkitt lymphoma. Human Pathology. 2024; doi:10.1016/j.humpath.2024.105703. B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org ...

  5. Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and researchers are studying cutaneous B-cell lymphoma to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...

  6. Lymphoma - Doctors and departments - Mayo Clinic

    Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...

  7. An Effectiveness And Safety Study Of Daratumumab In Relapsed/Resistant Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, And Follicular Lymphoma - Mayo Clinic

    Clinical Trials · An Effectiveness And Safety Study Of Daratumumab In Relapsed/Resistant Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, And Follicular ...

  8. Lymphoma Patients Event-Free Two Years after Diagnosis have a Normal Life Expectancy

    — Feb. 18, 2014 — Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years ...

  9. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

    ... cell lymphoma, a subset of B-cell lymphoma. It was also approved in February 2014 for use in CLL, following a study of the agent alone in patients with very ...

  10. Rituximab And Combination Chemotherapy With Or Without Lenalidomide In Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

    ... B cell lymphoma. Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy ...